Elevation Point Wealth Partners LLC Makes New $457,000 Investment in Plexus Corp. $PLXS

Elevation Point Wealth Partners LLC acquired a new stake in Plexus Corp. (NASDAQ:PLXS) during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 2,256 shares of the technology company’s stock, valued at approximately $457,000.

Several other institutional investors have also modified their holdings of the company. Covestor Ltd increased its holdings in Plexus by 207.7% in the fourth quarter. Covestor Ltd now owns 240 shares of the technology company’s stock valued at $35,000 after buying an additional 162 shares during the last quarter. Allworth Financial LP boosted its position in shares of Plexus by 70.1% during the 3rd quarter. Allworth Financial LP now owns 250 shares of the technology company’s stock worth $36,000 after acquiring an additional 103 shares in the last quarter. Johnson Financial Group Inc. purchased a new position in shares of Plexus in the 3rd quarter valued at about $72,000. Farther Finance Advisors LLC increased its holdings in shares of Plexus by 114.7% in the 4th quarter. Farther Finance Advisors LLC now owns 511 shares of the technology company’s stock valued at $75,000 after acquiring an additional 273 shares during the last quarter. Finally, EverSource Wealth Advisors LLC lifted its stake in Plexus by 583.3% during the second quarter. EverSource Wealth Advisors LLC now owns 574 shares of the technology company’s stock worth $78,000 after purchasing an additional 490 shares during the last quarter. 94.45% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts have commented on PLXS shares. Stifel Nicolaus increased their price target on shares of Plexus from $280.00 to $330.00 and gave the company a “buy” rating in a research note on Monday, June 22nd. Wall Street Zen upgraded shares of Plexus from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Needham & Company LLC boosted their price target on shares of Plexus from $285.00 to $310.00 and gave the company a “buy” rating in a research report on Monday, June 1st. Benchmark restated a “buy” rating and issued a $220.00 price objective on shares of Plexus in a research note on Monday, March 16th. Finally, Raymond James Financial reiterated an “outperform” rating and set a $275.00 target price on shares of Plexus in a research report on Thursday, April 30th. Five equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $246.67.

Insider Buying and Selling

In other news, insider Michael J. Running sold 510 shares of the firm’s stock in a transaction on Friday, June 5th. The shares were sold at an average price of $272.17, for a total value of $138,806.70. Following the completion of the sale, the insider owned 665 shares in the company, valued at approximately $180,993.05. This trade represents a 43.40% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Todd P. Kelsey sold 1,500 shares of the business’s stock in a transaction dated Wednesday, June 17th. The stock was sold at an average price of $294.98, for a total transaction of $442,470.00. Following the transaction, the chief executive officer owned 68,888 shares in the company, valued at approximately $20,320,582.24. This trade represents a 2.13% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 21,981 shares of company stock worth $5,855,318 over the last three months. 1.78% of the stock is owned by company insiders.

Plexus Price Performance

Shares of PLXS opened at $265.89 on Thursday. Plexus Corp. has a fifty-two week low of $115.35 and a fifty-two week high of $307.06. The company has a market capitalization of $7.12 billion, a price-to-earnings ratio of 38.87 and a beta of 0.88. The firm has a 50-day simple moving average of $274.88 and a 200-day simple moving average of $222.16. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.74 and a current ratio of 1.54.

Plexus (NASDAQ:PLXS) last issued its quarterly earnings results on Wednesday, April 29th. The technology company reported $2.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.87 by $0.18. The firm had revenue of $1.16 billion for the quarter, compared to analysts’ expectations of $1.13 billion. Plexus had a return on equity of 12.84% and a net margin of 4.35%.The firm’s revenue for the quarter was up 18.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.66 EPS. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. On average, equities research analysts anticipate that Plexus Corp. will post 5.98 earnings per share for the current year.

Plexus Profile

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.